Outcomes for Patients with Pre-Existing Diabetes or Hypertension Treated with Copanlisib from the CHRONOS-1 Study in Patients with Relapsed or Refractory Indolent B-Cell Lymphoma

被引：0

作者：

Zinzani, Pier Luigi ^{[1
]}

Santoro, Armando ^{[2
]}

Mollica, Luigina ^{[3
]}

Leppa, Sirpa ^{[4
]}

Follows, George A. ^{[5
]}

Lenz, Georg ^{[6
]}

Kim, Won Seog ^{[7
]}

Nagler, Arnon ^{[8
]}

Panayiotidis, Panayiotis ^{[9
]}

Demeter, Judit ^{[10
]}

Morschhauser, Franck ^{[11
]}

Rodrigues, Liana ^{[12
]}

Reeves, John ^{[13
]}

Hiemeyer, Florian ^{[14
]}

Miriyala, Ashok ^{[15
]}

Garcia-Vargas, Jose ^{[15
]}

Childs, Barrett H. ^{[15
]}

Dreyling, Martin H. ^{[16
]}

机构：

[1] Univ Bologna, Inst Hematol Seragnoli, Bologna, Italy

[2] IRCCS Humanitas Inst, Med Oncol, Milan, Italy

[3] Maisonneuve Rosemont Hosp Res Ctr, Montreal, PQ, Canada

[4] Univ Helsinki, Hosp Canc Ctr, Helsinki, Finland

[5] Cambridge Univ Hosp NHS Trust, Cambridge, England

[6] Univ Hosp Munster, Translat Oncol, Munster, Germany

[7] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea

[8] Tel Aviv Univ, Chaim Sheba Med Ctr, Tel Hashomer, Israel

[9] Univ Athens, Sch Med, Athens, Greece

[10] Semmelweis Univ, Budapest, Hungary

[11] CHRU, Hop Claude Huriez, Lille, France

[12] Bayer SA, Sao Paulo, Brazil

[13] Joule INC, Edison, NJ USA

[14] Bayer AG, Pharmaceut Div, Berlin, Germany

[15] Bayer HealthCare Pharmaceut, Whippany, NJ USA

[16] Klinikum Univ Munchen Grosshadern, Med Klin & Poliklin 3, Munich, Germany

来源：

BLOOD | 2018年 / 132卷

关键词：

D O I：

10.1182/blood-2018-99-117063

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1613

引用

下载

页数：4

共 50 条

[41] Copanlisib in Combination with Nivolumab in Subjects with Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Primary Mediastinal Large B-Cell Lymphoma: A Phase II Study
Bennani, N. Nora
Atherton, Pamela
Steinert, Kimberly O.
Rimsza, Lisa M.
Tun, Aung M.
Hoffmann, Marc S.
Narkhede, Mayur S.
Vaidya, Rakhee
Said, Rabih
Shapiro, Geoffrey I.
Costello, Brian A.
Ansell, Stephen M.
Nowakowski, Grzegorz S.
BLOOD, 2023, 142
[42] Correlation of Bridging and Lymphodepleting Chemotherapy with Clinical Outcomes in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Treated with Tisagenlecleucel
Andreadis, Charalambos
Tam, Constantine S.
Borchmann, Peter
Jaeger, Ulrich
McGuirk, Joseph P.
Holte, Harald
Waller, Edmund K.
Jaglowski, Samantha
Bishop, Michael R.
Foley, Stephen Ronan
Westin, Jason R.
Fleury, Isabelle
Ho, P. Joy
Mielke, Stephan
Teshima, Takanori
Salles, Gilles A.
Schuster, Stephen J.
Bachanova, Veronika
Maziarz, Richard T.
Van Besien, Koen
Izutsu, Koji
Magenau, John M.
Wagner-Johnston, Nina D.
Kato, Koji
Corradini, Paolo
Tiwari, Ranjan
Awasthi, Rakesh
Lawniczek, Tomasz
Eldjerou, Lamis K.
Kersten, Marie Jose
BLOOD, 2019, 134
[43] Higher Mortality in Patients With Diffuse Large B-cell Lymphoma Pre-Existing Arterial Hypertension - Real World Data of the Polish Lymphoma Research Group
Szmit, Sebastian
Dlugosz-Danecka, Monika
Drozd-Sokolowska, Joanna
Joks, Monika
Szeremet, Agnieszka
Jurczyszyn, Artur
Jurczak, Wojciech
HEART LUNG AND CIRCULATION, 2024, 33 (05): : 675 - 683
[44] A Phase I Study of the Combination of Rituximab and Ipilimumab in Patients with Relapsed/Refractory B-Cell Lymphoma
Tuscano, Joseph M.
Maverakis, Emanual
Groshen, Susan
Tsao-Wei, Denice
Luxardi, Guillaume
Merleev, Alexander A.
Beaven, Anne
DiPersio, John F.
Popplewell, Leslie
Chen, Robert
Kirschbaum, Mark
Schroeder, Mark A.
Newman, Edward M.
CLINICAL CANCER RESEARCH, 2019, 25 (23) : 7004 - 7013
[45] Urelumab alone or in combination with rituximab in patients with relapsed or refractory B-cell lymphoma
Timmerman, John
Herbaux, Charles
Ribrag, Vincent
Zelenetz, Andrew D.
Houot, Roch
Neelapu, Sattva S.
Logan, Theodore
Lossos, Izidore S.
Urba, Walter
Salles, Gilles
Ramchandren, Radhakrishnan
Jacobson, Caron
Godwin, John
Carpio, Cecilia
Lathers, Deanne
Liu, Yali
Neely, Jaclyn
Suryawanshi, Satyendra
Koguchi, Yoshinobu
Levy, Ronald
AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (05) : 510 - 520
[46] Safety and antitumor activity of copanlisib in Japanese patients with relapsed/refractory indolent non-Hodgkin lymphoma: a phase Ib/II study
Noriko Fukuhara
Dai Maruyama
Kiyohiko Hatake
Hirokazu Nagai
Shinichi Makita
Kenjiro Kamezaki
Toshiki Uchida
Shigeru Kusumoto
Junya Kuroda
Chisako Iriyama
Masamitsu Yanada
Norifumi Tsukamoto
Youko Suehiro
Hironobu Minami
Jose Garcia-Vargas
Barrett H. Childs
Masanobu Yasuda
Shigeo Masuda
Toshiaki Tsujino
Yui Terao
Kensei Tobinai
International Journal of Hematology, 2023, 117 : 100 - 109
[47] A multicenter phase II study of vorinostat in patients (pts) with relapsed or refractory indolent B-cell non-Hodgkin lymphoma (B-NHL) or mantle cell lymphoma (MCL).
Ando, Kiyoshi
Ogura, Michinori
Suzuki, Tatsuya
Ishizawa, Kenichi
Oh, Sung Yong
Kim, Won Seog
Tanaka, Yoshinobu
Shimamoto, Takashi
Tobinai, Kensei
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[48] Safety and antitumor activity of copanlisib in Japanese patients with relapsed/refractory indolent non-Hodgkin lymphoma: a phase Ib/II study
Fukuhara, Noriko
Maruyama, Dai
Hatake, Kiyohiko
Nagai, Hirokazu
Makita, Shinichi
Kamezaki, Kenjiro
Uchida, Toshiki
Kusumoto, Shigeru
Kuroda, Junya
Iriyama, Chisako
Yanada, Masamitsu
Tsukamoto, Norifumi
Suehiro, Youko
Minami, Hironobu
Garcia-Vargas, Jose
Childs, Barrett H.
Yasuda, Masanobu
Masuda, Shigeo
Tsujino, Toshiaki
Terao, Yui
Tobinai, Kensei
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2023, 117 (01) : 100 - 109
[49] Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
Ohmachi, Ken
Ando, Kiyoshi
Ogura, Michinori
Uchida, Toshiki
Itoh, Kuniaki
Kubota, Nobuko
Ishizawa, Kenichi
Yamamoto, Joji
Watanabe, Takashi
Uike, Naokuni
Choi, Ilseung
Terui, Yasuhito
Usuki, Kensuke
Nagai, Hirokazu
Uoshima, Nobuhiko
Tobinai, Kensei
CANCER SCIENCE, 2010, 101 (09) : 2059 - 2064
[50] Patient-reported outcomes data from a phase 2 study of idelalisib in patients with refractory indolent B-cell non Hodgkin lymphoma (iNHL)
Wagner-Johnston, Nina D.
Gopal, Ajay K.
Kahl, Brad S.
De Vos, Sven
Schuster, Stephen J.
Jurczak, Wojciech
Flinn, Ian
Flowers, Christopher
Martin, Peter
Viardot, Andreas
Blum, Kristio A.
Goy, Andre
Davies, Andrew John
Zinzani, Pier Luigi
Dreyling, Martin H.
Wagner, Lynne I.
Sorensen, Bess
Godfrey, Wayne Russell
Salles, Gilles A.
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)

← 1 2 3 4 5 →